Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116844794 | 11684479 | 4 | F | 20150928 | 20160826 | 20151029 | 20160902 | EXP | US-PFIZER INC-2015355849 | PFIZER | 61.00 | YR | M | Y | 91.00000 | KG | 20160902 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116844794 | 11684479 | 1 | PS | INLYTA | AXITINIB | 1 | Oral | 5 MG, 2X/DAY | Y | M49372 | 202324 | 5 | MG | FILM-COATED TABLET | BID | ||||
| 116844794 | 11684479 | 2 | SS | INLYTA | AXITINIB | 1 | Oral | 10 MG, 2X/DAY | Y | 202324 | 10 | MG | FILM-COATED TABLET | BID | |||||
| 116844794 | 11684479 | 3 | SS | INLYTA | AXITINIB | 1 | Oral | 3 MG, 2X/DAY | Y | 202324 | 3 | MG | FILM-COATED TABLET | BID | |||||
| 116844794 | 11684479 | 4 | SS | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, 1X/DAY | 20987 | 40 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 116844794 | 11684479 | 5 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | TABLET | QD | ||||||
| 116844794 | 11684479 | 6 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 50 UG, 1X/DAY | 0 | 50 | UG | TABLET | QD | ||||||
| 116844794 | 11684479 | 7 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 100 MG, 2X/DAY | 0 | 100 | MG | TABLET | BID | ||||||
| 116844794 | 11684479 | 8 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 45 MG, 1X/DAY (BEDTIME) | 0 | 45 | MG | TABLET | QD | ||||||
| 116844794 | 11684479 | 9 | C | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4 MG, DAILY | 0 | .4 | MG | ||||||||
| 116844794 | 11684479 | 10 | C | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0.4 MG, 1X/DAY | 0 | .4 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116844794 | 11684479 | 1 | Renal cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116844794 | 11684479 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116844794 | 11684479 | Blood pressure increased | |
| 116844794 | 11684479 | Disease progression | |
| 116844794 | 11684479 | Headache | |
| 116844794 | 11684479 | Renal cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |